|Articles|April 1, 2017
- Pharmaceutical Executive-04-01-2017
- Volume 37
- Issue 4
Pharmaceutical Executive, April 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
HBA's Woman of the Year 2017about 9 years ago
Sales Force Effectiveness, Millennial Styleabout 9 years ago
The Lengthening Arm of Pharmacovigilanceabout 9 years ago
When Rare Becomes Commonabout 9 years ago
Advancing Rare Disease R&D: A Mission Updateabout 9 years ago
A Faster, More Flexible, and Frugal FDA?about 9 years ago
Country Report: GreeceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5